Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists
{{output}}
Previous studies documented that human bladder cancer cells are sensitive to the apoptotic effects of quinazoline-derived α1-adrenoreceptor antagonists and bladder tumors exhibit reduced tissue vascularity in response to terazosin. More recent evidence sugges... ...
